Cystadenocarcinoma, Mucinous - 25 Studies Found Active, not recruiting : Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer : Fallopian Tube Cancer Ovarian Clear Cell Cystadenocarcinoma Biological: denileukin diftitox Completed : Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma : Brenner Tumor Fallopian Tube Cancer Ovarian Clear Cell Cys : 2003-05-06 : Drug: paclitaxel Given IV Completed : Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer : Brenner Tumor Ovarian Clear Cell Cystadenocarcinoma Ovaria : 1999-11-01 : Drug: paclitaxel Given IV Recruiting : TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors : Adult Glioblastoma Endometrial Clear Cell Adenocarcinoma E : 2014-05-16 : Biological: Bevacizumab Given Completed : Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin : Brenner Tumor Fallopian Tube Cancer Ovarian Clear Cell Cys : 2009-10-09 : Drug: belinostat Given IV Completed : A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer : Fallopian Tube Carcinoma Malignant Ovarian Mixed Epithelial Tumor Biological: Urokinase-Derived Peptide A6 Completed : Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy : Brenner Tumor Fallopian Tube Cancer Ovarian Clear Cell Cys : 2007-04-25 : Biological: sargramostim Given Completed : Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer : Brenner Tumor Fallopian Tube Cancer Ovarian Clear Cell Cys : 2004-03-08 : Procedure: adjuvant therapy Drug: paclitax Completed : Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer : Fallopian Tube Carcinoma Malignant Ovarian Mixed Epithelial Tumor Drug: Carboplatin Given IV Recruiting : Vaccine Therapy in Treating Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer Following Surgery and Chemotherapy : Fallopian Tube Clear Cell Adenocarcinoma Fallopian Tube Endometrioid Tumor Other: Laboratory Biomarker Analysis <<< Previous | Next >>>